510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K213348Substantially Equivalent

BOND MMR Antibody Panel

Leica Biosystems Newcastle Ltd., Newcastle Upon Tyne, GB / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K213348 is the FDA 510(k) clearance record for BOND MMR Antibody Panel, a class II device, cleared for Leica Biosystems Newcastle, Ltd. on under FDA product code PZJ (Lynch Syndrome Test System). FDA's definition for product code PZJ reads: "The Lynch syndrome test system is used to identify loss of DNA mismatch repair proteins or microsatellite instability in tumor tissue from cancer patients for the purpose of identifying patients who may benefit from additional testing for...". FDA records list 6 510(k) clearances for Leica Biosystems Newcastle, Ltd., from to . As of , FDA records show no recalls naming K213348.

Clearance record

Decision date
Received
(501 days to decision)
Product code
PZJ Lynch Syndrome Test System
Regulation
21 CFR 864.1866
Device class
Class II
Review panel
Immunology
Applicant
Leica Biosystems Newcastle, Ltd. Balliol Business Park W., Newcastle Upon Tyne, GB
510(k) summary
Summary PDF
Third party review
No

Clearances, product code PZJ

Trailing 12 months

FDA records hold no clearances under product code PZJ in the trailing twelve months.

FDA records show no clearances under product code PZJ in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code PZJ, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260